<DOC>
	<DOCNO>NCT00269126</DOCNO>
	<brief_summary>This study compare effect two medicine COPD ( Chronic Obstructive Pulmonary Disease ) . This study last 18 week , subject visit clinic 5 time . Subjects give breathe test , record breathing symptom daily diary card .</brief_summary>
	<brief_title>Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease ( Chronic Bronchitis , Emphysema )</brief_title>
	<detailed_description>Clinical Evaluation GW815SF Chronic Obstructive Pulmonary Disease ( Chronic Bronchitis , Emphysema ) `` Assessment Effect Addition Fluticasone Dipropionate Salmeterol Xinafoate 50µg Switching Double-blinded condition GW815SF 50/250µg Chronic Obstructive Pulmonary Disease</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Diagnosis COPD . Exclusion criterion : Diagnosis asthma uncontrolled medical condition respiratory disorder COPD . Other inclusion exclusion criterion evaluate first study visit .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>COPD</keyword>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>Emphysema</keyword>
</DOC>